Jin-an Jiao is VP of Development at HCW Biologics Inc. (HCWB). They have made 1 open-market trade across 1 company since 2021, most recently 2022-05-31.
CIK 0001866271
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $24K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HCWB | 45,141 | $56K |
Shares reported on the most recent Form 4, priced at the 2022-06-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HCWB | BUY | 2021-12-06 | 2021-12-07 | $2.42 | $24K | -4.5% | -13.2% | -18.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.